Long-term repeatability of induced sputum cells and inflammatory markers in stable, moderately severe COPD

被引:58
作者
Beeh, KM [1 ]
Beier, J [1 ]
Kornmann, O [1 ]
Mander, A [1 ]
Buhl, R [1 ]
机构
[1] Univ Hosp, Dept Pulm, D-55131 Mainz, Germany
关键词
COPD; induced sputum; interleukin-8; neutrophils; repeatability; soluble intercellular adhesion molecule;
D O I
10.1378/chest.123.3.778
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Study objectives: Neutrophilic inflammation is a major feature of COPD. Induced sputum is increasingly used to monitor inflammatory airway diseases. Although short-term repeatability of selected sputum markers has been extensively studied in several populations, data on the long-term repeatability of induced sputum markers in stable COPD are scant. Design: Sputum supernatant of 12 patients with stable COPD was analyzed on three separate occasions with 4-weekly intervals. Sputum cells and inflammatory markers interleukin (IL)-8 and soluble intercellular adhesion molecule (sICAM)-1 were measured in supernatant using enzyme-linked immunosorbent assay. Repeatability of sputum markers was expressed by intraclass correlation coefficients (Ri). Measurements and results: Sputum induction was safe in all patients. None of the sputum parameters analyzed changed significantly throughout the study. The repeatability for cell differential counts instable COPD was as follows: total cells, Ri=0.07; neutrophils, Ri=0.66; macrophages, Ri=0.47; eosinophils, Ri=0.49; and lymphocytes, Ri=0.58. The repeatability of soluble markers was as follows: IL-8, Ri=0.50; and sICAM, Ri=0.58. Sputum neutrophils were negatively correlated with lung function on each separate occasion, whereas soluble markers were not correlated with sputum cells (p>0.16, all correlations) or lung function (p>0.24, all correlations). Conclusions: Clinically stable, moderate COPD is associated with equally stable sputum inflammatory markers. Repeatability of induced-sputum markers of neutrophilic inflammation in stable COPD is satisfactory, even over extended periods of time. These data support the usefulness of serial monitoring of induced-sputum inflammatory markers in COPD.
引用
收藏
页码:778 / 783
页数:6
相关论文
共 44 条
  • [1] Chemokines: Leucocyte recruitment and activation cytokines
    Adams, DH
    Lloyd, AR
    [J]. LANCET, 1997, 349 (9050) : 490 - 495
  • [2] [Anonymous], 1987, AM REV RESPIR DIS, V136, P1285
  • [3] Inhaled corticosteroids in stable COPD patients - Do they have effects on cells and molecular mediators of airway inflammation?
    Balbi, B
    Majori, M
    Bertacco, S
    Convertino, G
    Cuomo, A
    Donner, CF
    Pesci, A
    [J]. CHEST, 2000, 117 (06) : 1633 - 1637
  • [4] Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
    Bhowmik, A
    Seemungal, TAR
    Sapsford, RJ
    Wedzicha, JA
    [J]. THORAX, 2000, 55 (02) : 114 - 120
  • [5] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [6] Induced sputum and other outcome measures in chronic obstructive pulmonary disease: safety and repeatability
    Brightling, CE
    Monterio, W
    Green, RH
    Parker, D
    Morgan, MDL
    Wardlaw, AJ
    Pavord, ID
    [J]. RESPIRATORY MEDICINE, 2001, 95 (12) : 999 - 1002
  • [7] REPEATABILITY AND METHOD COMPARISON
    CHINN, S
    [J]. THORAX, 1991, 46 (06) : 454 - 456
  • [8] Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease
    Culpitt, SV
    Maziak, W
    Loukidis, S
    Nightingale, JA
    Matthews, JL
    Barnes, PJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (05) : 1635 - 1639
  • [9] EXPRESSION OF GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR, INTERLEUKIN-8 AND RANTES IN THE BRONCHIAL EPITHELIUM OF MILD ASTHMATICS IS DOWN-REGULATED BY INHALED BECLOMETHASONE DIPROPIONATE
    DAVIES, RJ
    WANG, JH
    TRIGG, CJ
    DEVALIA, JL
    [J]. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) : 428 - 429
  • [10] de Boer WI, 2000, J PATHOL, V190, P619, DOI 10.1002/(SICI)1096-9896(200004)190:5<619::AID-PATH555>3.0.CO